Kangmei Pharmaceutical Co.,Ltd. Posted 195.5 Million Yuan Net Loss in First Half of 2022

Kangmei Pharmaceutical Co.,Ltd. (康美药业股份有限公司) (600518.SH) reported a net loss of 195.5 million yuan in the first half of 2022, narrowing 79% year-on-year.

Meanwhile, the company posted 1.8 billion yuan in revenue, down 14% year-on-year.

At the end of the reporting period, it had 15.7 billion yuan in total assets and 5.9 billion yuan in total liabilities, with a liability-to-asset ratio of 37.6%.